Insider · CIK 0001844594
Steven Weber
officer
Files at IGMS (IGM Biosciences, Inc.), PLSE (PULSE BIOSCIENCES, INC.). First filing Dec 18, 2024, latest Jun 20, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $11k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | IGM Biosciences, Inc. | $583 486 shares | -2% | - | |
| 15Weak | IGMSsell IGM Biosciences, Inc. | $2,090 1,865 shares | -6% | - | |
| 30Weak | IGM Biosciences, Inc. | $2,092 1,701 shares | -6% | - | |
| 15Weak | IGMSsell IGM Biosciences, Inc. | $1,907 1,122 shares | -4% | - | |
| 30Weak | IGM Biosciences, Inc. | $4,032 539 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 14, 2025 | PLSE PULSE BIOSCIENCES, INC. | AGrant or award Stock Option (right to buy)derivative | +55,000 | $0.00 | $0 | 55,000 | Jul 16, 2025 |
| Jun 16, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -486 | $1.20 | $583 | 26,530 | Jun 20, 2025 |
| May 14, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -1,865 | $1.12 | $2,090 | 27,016 | May 16, 2025 |
| Mar 14, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -1,701 | $1.23 | $2,092 | 28,881 | Mar 18, 2025 |
| Jan 15, 2025 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -1,122 | $1.70 | $1,907 | 30,582 | Jan 17, 2025 |
| Dec 16, 2024 | IGMS IGM Biosciences, Inc. | SOpen-market sale Common Stock | -539 | $7.48 | $4,032 | 31,704 | Dec 18, 2024 |
| Nov 7, 2024 | IGMS IGM Biosciences, Inc. | AGrant or award Common Stock | +6,700 | $0.00 | $0 | 32,243 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.